Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
Authors
Keywords
Viral replication, Breast cancer, Cancer treatment, Hydroxamic acids, Epithelial cells, Oncolytic viruses, Carcinomas, Histones
Journal
PLoS One
Volume 9, Issue 3, Pages e92919
Publisher
Public Library of Science (PLoS)
Online
2014-03-21
DOI
10.1371/journal.pone.0092919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
- (2013) Sarah C. Darby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- The Histone Deacetylase Inhibitor Valproic Acid Lessens NK Cell Action against Oncolytic Virus-Infected Glioblastoma Cells by Inhibition of STAT5/T-BET Signaling and Generation of Gamma Interferon
- (2012) Christopher A. Alvarez-Breckenridge et al. JOURNAL OF VIROLOGY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Rethinking herpes simplex virus: the way to oncolytic agents
- (2011) Gabriella Campadelli-Fiume et al. REVIEWS IN MEDICAL VIROLOGY
- Oncolytic viruses and histone deacetylase inhibitors—A multi-pronged strategy to target tumor cells
- (2010) Thi Lien-Anh Nguyen et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?
- (2010) Ryuichi Kanai et al. Future Oncology
- Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors
- (2010) Heather MacTavish et al. PLoS One
- Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model
- (2009) Douglas R. Hurst et al. CLINICAL & EXPERIMENTAL METASTASIS
- Intelligent Design: Combination Therapy With Oncolytic Viruses
- (2009) Kathryn Ottolino-Perry et al. MOLECULAR THERAPY
- Histone deacetylase inhibitors: Anticancer compounds
- (2008) Karen T. Smith et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells
- (2008) Douglas R. Hurst et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses
- (2008) Akihiro Otsuki et al. MOLECULAR THERAPY
- Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
- Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
- (2008) T. L.-A. Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started